YPrime, a clinical trial technology company delivering eCOA, IRT, and eConsent solutions, has promoted Greg Wellbrock to Chief Data and AI Officer. Wellbrock previously served as the company’s Vice President of Architecture and Data, leading architecture, data engineering, and analytics.

In his new role, Wellbrock leads YPrime’s data, architecture, and AI strategy, focusing on modernizing data platforms and advancing AI-driven innovation and intelligent automation. The initiatives aim to help sponsors access reliable clinical trial data faster, streamline operations, and make better decisions throughout the study lifecycle.

During his more than two years at YPrime, Wellbrock has led the company’s data organization and guided its AI initiatives. These efforts have helped accelerate study configuration, implement mid-study protocol changes more efficiently, and deliver product enhancements on compressed timelines while maintaining clinical research quality standards.

Commenting on the appointment, Wellbrock said, “Our focus is not AI for its own sake. It is about helping sponsors gain faster access to reliable information, automate routine processes, reduce execution risk, and make better decisions throughout a study. Bringing data and AI together under a unified strategy allows us to deliver even greater value for our customers.”